Welcome to the SCW blog, where we share practical insights on building faster, more resilient, and more compliant supply chains in life sciences and other regulated industries. Here, we translate real transformation work into clear takeaways, from strategy to execution, so teams can move from “where do we start?” to measurable impact.
A practical DSCSA exception handling playbook covering triage workflows, queue design, SLA targets, escalation paths, and the roles that make investigations resolve on time.
A step-by-step guide to running a DSCSA traceability fire drill – from suspect product identification through investigation, FDA notification, and resolution – before a real event tests your readiness.
AI readiness in pharma starts with trusted data. Learn the minimum foundation needed before AI can improve operations, quality, and supply chain decisions.
AI is accelerating supply chain planning, but weak architecture still slows execution. See why RPA, governed data, and workflow discipline matter first.
Compliance maturity is measured by the consistency and control of day-to-day operations long after go-live, not by the success of the implementation itself. This is why EPCIS 2.0 matters.
NMVO country guide for MAHs: compare alert timelines, understand EAMS workflows, and standardize investigations across Europe with audit-ready playbooks.
When an EMVS alert traces back to a CMO, investigation speed depends on the coordination model you built before the alert arrived. Here’s how to design it.
Digital Factory maturity has moved well past the stage of being a strategic aspiration. In 2026, it is an operational imperative, the backbone of a resilient pharma supply chain, one that determines whether your site can release products faster, sustain compliance under regulatory scrutiny, and scale without the kind of constant firefighting that quietly erodes capacity and morale.
The pharma supply chain is not a forgiving environment for shortcuts. The processes are complex, the regulatory exposure is real, and the downstream impact of poor data or unclear ownership is significant. Autonomous actions, at any meaningful scale, require you to have already solved for that complexity, not planned to solve it later.
